Jump to content

COMPLi: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Added proper references
m Added an Info box
Line 1: Line 1:
<!-- Please do not remove or change this AfD message until the discussion has been closed. -->
<!-- Please do not remove or change this AfD message until the discussion has been closed. -->
{{Article for deletion/dated|page=COMPLi|timestamp=20230720233014|year=2023|month=July|day=20|substed=yes|help=off}}
{{Article for deletion/dated|page=COMPLi|timestamp=20230720233014|year=2023|month=July|day=20|substed=yes|help=off}}{{Infobox company
| name = COMPL.i
⚫
<!-- Once discussion is closed, please place on talk page: {{Old AfD multi|page=COMPLi|date=20 July 2023|result='''keep'''}} -->
| logo = COMPLi. Logo.png
| founded = 2017
| founder = Scientist.com
⚫
}}<!-- Once discussion is closed, please place on talk page: {{Old AfD multi|page=COMPLi|date=20 July 2023|result='''keep'''}} -->
<!-- End of AfD message, feel free to edit beyond this point -->
<!-- End of AfD message, feel free to edit beyond this point -->
{{Orphan|date=July 2023}}
{{Orphan|date=July 2023}}

Revision as of 16:54, 26 July 2023

COMPL.i
Founded2017
FounderScientist.com

COMPLi® is a first-of-its kind compliance platform that was launched by Scientist.com in collaboration with the top 25 pharmaceutical companies, contract research organizations (CROs) and biobanks in 2017.[1][2]

History

As global policies on the provision of biological specimens used for research are not aligned and can be difficult to adhere to for a global pharmaceutical company,  COMPLi was launched in order to improve compliance, oversight and governance through proactive collection of information coupled with bespoke contracts and enhanced compliance tools.[3] COMPLi ultimately reduces the administrative burden and inherent risks pharmaceutical companies, biotechs and academic labs face when sourcing regulated services and materials from external third parties.[4]

In 2018, COMPLi received the Excellence in Pharma: Regulatory and Compliance Framework award at the 2018 CPhI Pharma Awards.[5] By 2019, Scientist.com added animal welfare, secondary real-world evidence (RWE), health economics and outcomes research (HEOR), and GxP services to the COMPLi functionality.[6] In 2020, Scientist.com partnered with UK biobanks and large pharmaceutical companies to see how COMPLi could help solve challenges biobanks face when working with industry partners.[7] Later in 2020, Scientist.com launched the COMPLi HBS Legislation Series, an ongoing educational webinar series intended to inform researchers of the varying regulations governing biological specimen acquisition globally.[8][9][10][11] By the end of 2020, Scientist.com expanded COMPLi to include VERIF.i, a supplier pre-assessment program designed with input from multiple large pharmaceutical companies to enable proactive pre-assessments of suppliers in various higher risk areas such as biological specimen provision, animal welfare and Chemistry Manufacturing and Controls (CMC).[12]

In 2021, Scientist.com partnered with Enhancing Quality in Preclinical Data (EQIPD) to better monitor and enhance the role that preclinical quality certifications can play in fostering biopharma-CRO relationships—through COMPLi, a preclinical service provider can now self-certify against the EQIPD standard and promote this to organizations to increase confidence in the quality of data being generated through outsourcing.[13] Also in 2021, Scientist.com was named one of the top 10 Pharma Compliance Service Companies by Pharma Tech Outlook for its COMPLi and VERIF.i solutions.[14]

References

  1. ^ Demery, Paul (2017-10-02). "A new online marketplace service for biotech researchers". Digital Commerce 360. Retrieved 2023-07-25.
  2. ^ outsourcing-pharma.com (2017-10-04). "Add to cart: Online marketplaces join forces to provide researchers instant access to biospecimens". outsourcing-pharma.com. Retrieved 2023-07-25.
  3. ^ COMPLi: For Regulated Services, retrieved 2023-07-25
  4. ^ "The Threat of a Black Market Within the Market: The Hidden Risks of Sourcing Human Biological Samples". Scientist.com. 2018-04-23. Retrieved 2023-07-25.
  5. ^ "CPhI Announces Pharma Award Winners". PharmExec. 2018-10-10. Retrieved 2023-07-25.
  6. ^ outsourcing-pharma.com (2019-10-28). "Scientist.com adds animal welfare module to compliance solution". outsourcing-pharma.com. Retrieved 2023-07-25.
  7. ^ "Video: Overcoming Challenges in UK Biobanking Webinar Series Debrief". Scientist.com. 2020-09-29. Retrieved 2023-07-25.
  8. ^ "Video: Navigating Regulations for Sourcing Human Biological Samples in Russia". Scientist.com. 2020-11-17. Retrieved 2023-07-25.
  9. ^ "COMPLi® HBS Legislation Series: India". Scientist.com. 2021-01-23. Retrieved 2023-07-25.
  10. ^ "Video: COMPLi HBS Legislation Series: Ukraine". Scientist.com. 2021-05-19. Retrieved 2023-07-25.
  11. ^ "COMPLi HBS Legislation Series: France". Scientist.com. 2023-06-08. Retrieved 2023-07-25.
  12. ^ Forbes, Kristina (2020-06-24). "Scientist.com Expands Award-Winning COMPLi® Platform to include VERIF.i®, a Supplier Pre-assessment Program". Georgia Bio. Retrieved 2023-07-25.
  13. ^ "How Preclinical Quality Certifications Help Foster Biopharma-CRO Partnerships [Webinar]". Scientist.com. 2021-07-02. Retrieved 2023-07-25.
  14. ^ "Scientist.com | Pharma Compliance Service Company-2021". Pharma Tech Outlook. Retrieved 2023-07-25.
Retrieved from "https://en.wikipedia.org/w/index.php?title=COMPLi&oldid=1167250956"